Filing Flows › Coya Therapeutics (COYA) › Q2 2025
Coya Therapeutics (COYA) Q2 2025 earnings results (second quarter 2025)
10-Q filed Aug 12, 2025
Coya Therapeutics (COYA) reported revenue of $164K for the second quarter 2025 (Q2 2025), -95% from a year earlier and -37% from the quarter before.
Coya Therapeutics, Q2 2025: revenue $164K (-95% year over year), net loss $6.1M, operating cash flow −$5.8M. The chart follows the revenue to costs, profit and cash.
| Q2 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $164K | -37% | -95% |
| Operating profit | −$6.4M | — | — |
| Net earnings | −$6.1M | — | — |
| Operating cash flow | −$5.8M | — | — |
What changed
Revenue was $164K in Q2 2025, down 95% year over year and down 37% from the previous quarter.
Operating costs exceeded revenue by $6.4M, an operating margin of -3920.5%. Total costs fell 1% while revenue fell 95%. The fastest-growing cost line was General & admin (+39%). The quarter ended with a net loss of $6.1M, narrower than the previous quarter's $7.3M loss.
Operating cash flow was −$5.8M. Non-cash charges added back $7K of depreciation and $1.0M of share-based compensation. Working capital and other items used $721K.
Questions
What was Coya Therapeutics' revenue in the second quarter 2025?
Coya Therapeutics (COYA) reported revenue of $164K for the second quarter 2025 (Q2 2025), -95% from a year earlier and -37% from the quarter before.
Source: Coya Therapeutics 10-Q on SEC EDGAR.